LABS.TO

MediPharm Labs Corp.

C$0.07

-7.14%
SectorHealthcareIndustryDrug Manufacturers - Specialty & GenericCountryCanadaExchangeTSX · CAD
Q-Score52/ 100
Market CapC$27.8M
P/E—
Dividend Yield0.00%
52-Week Range—
Next Earnings—
Analysts—
Beta0.84
AI summary

Price & performance

1M-7.1%
3M-13.3%
YTD-7.1%
1Y-7.1%
52-week range—
Beta0.84
Full chart and returns against a benchmark

Q-Score

52/ 100

Quality against peers; 50 is the peer median.

Growth42
Risk57
Performance56
Valuation63
Profitability52
Leverage30
Sentiment—
Every score and metric

News sentiment

Open News

Latest results · FY 2025

RevenueC$45.1M+7.5%
Net income-C$8.3M
Net margin-18.3%+7.2 pts
Historical fundamentals

Valuation

LABS.TOIndustryP/E—37.50P/S0.672.82EV/EBITDA—16.62P/B0.782.54PEG—0.74
Dividend yield0.00%
Every valuation metric